Dare Bioscience
DARE
18 hedge funds and large institutions have $842K invested in Dare Bioscience in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 0 closing their positions.
20% more funds holding
Funds holding: 15 → 18 (+3)
0.07% more ownership
Funds ownership: 0.56% → 0.63% (+0.07%)
6% less capital invested
Capital invested by funds: $899K → $842K (-$57.2K)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$80.2K |
| 2 |
Renaissance Technologies
New York
|
+$56.2K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
+$31.3K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$12.2K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.64K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$51.7K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$15.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$6.25K |
| 4 |
Barclays
London,
United Kingdom
|
-$2.69K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PVMCV
1
Polaris Venture Management Co V
Boston,
Massachusetts
| $318K | – | – | – |
|
|
2
Renaissance Technologies
New York
| $111K | +$56.2K | +4,175 | +78% |
|
|
3
Citadel Advisors
Miami,
Florida
| $104K | +$80.2K | +5,956 | +205% |
|
|
PAM
4
Panagora Asset Management
Boston,
Massachusetts
| $79K | -$15.1K | -1,121 | -14% |
|
|
5
Vanguard Group
Malvern,
Pennsylvania
| $57K | +$1.64K | +122 | +3% |
|
6
Geode Capital Management
Boston,
Massachusetts
| $56K | – | – | – |
|
|
BFM
7
Boothbay Fund Management
New York
| $34K | – | – | – |
|
|
VF
8
Virtu Financial
New York
| $27K | -$51.7K | -3,844 | -63% |
|
|
ARTA
9
A.R.T. Advisors
New York
| $27K | +$31.3K | +2,328 | New |
|
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $11K | +$12.2K | +907 | New |
|
11
Northern Trust
Chicago,
Illinois
| $10K | – | – | – |
|
|
12
Barclays
London,
United Kingdom
| $5K | -$2.69K | -200 | -30% |
|
13
BlackRock
New York
| $1K | – | – | – |
|
14
Bank of America
Charlotte,
North Carolina
| $1K | +$754 | +56 | New |
|
|
AWA
15
Artemis Wealth Advisors
New York
| $859 | – | – | – |
|
|
16
UBS Group
Zurich,
Switzerland
| – | -$6.25K | -464 | -95% |
|
DARE Hedge Fund Activity: Q3 2018 in Review
18 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q3 2018, worth a combined $842K — down 6.4% from $899K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new DARE positions and 0 closed out — a net gain of 3 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $80.2K. The largest seller was Virtu Financial, cutting an estimated $51.7K.
- 18 institutional investors held Dare Bioscience (DARE) as of Q3 2018, up from 15 in Q2 2018.
- Funds reported $842K of Dare Bioscience stock for Q3 2018, down 6.4% quarter-over-quarter.
- 3 funds opened new Dare Bioscience positions in Q3 2018 and 0 closed out, a net change of +3 holders.
- The largest Dare Bioscience buyer in Q3 2018 was Citadel Advisors, an estimated $80.2K added.
- The largest Dare Bioscience seller in Q3 2018 was Virtu Financial, an estimated $51.7K sold.
Based on aggregated 13F filings for Q3 2018.